Compare Abeona Therapeutics Inc (ABEO) vs Old Dominion Freight Line Inc (ODFL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Old Dominion Freight Line Inc — how do they compare? Abeona Therapeutics Inc trades at $6.78 (market cap $373.32M), while Old Dominion Freight Line Inc trades at $218.13 (market cap $44.82B). The key difference: Old Dominion Freight Line Inc is far larger — about 120.1× Abeona Therapeutics Inc's market cap, and Old Dominion Freight Line Inc pays a 0.54% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | ODFL | |
|---|---|---|
Market Cap | $373.32M | $44.82B |
Sector | Health | Industrials |
52-Week High | $7.23 | $248.73 |
52-Week Low | $4.17 | $126.29 |
Enterprise Value | $228.22M | $44.58B |
Dividend Yield | — | 0.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
ODFL trades at $215.51, down 0.98% today, with technical indicators showing a bearish trend near support at $214. The company maintains strong fundamentals with a Q1 2026 EPS beat of $1.14 versus $1.05 expected, though revenue declined to $5.5B in 2025. Valuation remains elevated with a P/E of 45.18 and P/S of 8.35, while profitability metrics like ROE of 23.33% and net margin of 18.46% highlight operational efficiency.
The outlook is mixed: analyst consensus targets $230.69 with 33% buy ratings, but near-term risks include Amazon's LTL expansion (Barron's, June 10, 2026) and high valuation concerns. Cash flow stability and debt-free balance sheet support long-term potential, though investors face headwinds from freight market volatility and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →
